Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC

NCT04275713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Metformin
DRUG: Cisplatin

Sponsor

Oslo University Hospital